According to news reports, Columbia University has just entered Phase II of its mesothelioma clinical trial in which two chemotherapy drugs are being tested. The trial is aimed at treating malignant pleural mesothelioma and peritoneal mesothelioma, which are two of the more deadly types of mesothelioma.
The trial will involve approximately 29 individuals and will last nearly six months.
Researchers from Georgetown University Medical Center in Washington D.C. recently published an article in the journal Nature Medicine on the potential link between Alzheimer's disease and those who have previously suffered from a traumatic brain injury.
According to a Reuter's news report on the study, Alzheimer's disease is "associated with accumulations of an abnormal protein, amyloid beta, in the brain.
Recently, the Peanut Corporation of America (PCA) issued a recall of peanut butter manufactured from its Blakely, Georgia production plant after reports from nearly 500 individuals who had developed salmonella poisoning because of infected peanut butter flooded health officials.
The contaminated peanut butter has caused at least seven known deaths and is expected to continue to affect individuals across the United States as the contaminated peanut butter has been used in several varying products ranging from crackers to cookies.
A study currently being conducted in Boston, Mass., by several physicians is attempting to determine the highest level of medicinal treatments, such as chemotherapy, that can be administered to mesothelioma victims in order to more adequately treat symptoms of the killer lung disease.
Researchers are using two methods of treatment known as intraoperative intracavitary hyperthermic cisplatin perfusion along with amifostine, to assist in preventing cisplatin toxicity, to patients suffering from malignant pleural mesothelioma, which is often deemed the most severe and fatal diagnosis among mesothelioma patients.
Researchers have found that disparities may exist between the survival of lung cancer patients between various races, particularly among African Americans who are at a greater risk of fatality following a lung cancer diagnosis compared to those of other races, according to a report from the University of Washington, Seattle researchers.
The study used informational data from 17,739 patients that were of the average age of 75 years old.
Scientists have developed a new method of administering a mild electrical current to improve motor skills in a traumatic brain injury victim.
The newly discovered method of treatment was published in the Proceedings of the National Academy of Sciences. The study followed subjects who had suffered from stroke and traumatic brain injury (TBI) and placed victims in a duration of tests including squeezing a joy stick during a computerized targeting game.
Scientists recently discovered an astonishing new association related to the onset of osteoporosis among patients. The relationship, which is between bone metabolism and depression is becoming more prevalent, according to a study published in a recent issue of European Journal Psychotherapy.
The study found that through the analyzation of data between 1994 and 2007, the "association between psychiatric illness, particularly depression, and osteoporosis been the subject of a growing body of research," and the increased interest between the two issues is resulting in much validity, according to researchers.
The University of Colorado Hospital has recently embarked on what news reports have deemed a "groundbreaking medical trial" for patients suffering from pancreatic cancer. The trial uses a new technique designed to "shrink the tumor with very concentrated, very localized medication," according to 7 Denver News, a local television news casting station.
Medical professionals recently began administering a new method of therapeutic hypothermia to cardiac arrest patients and found that the method was successful compared to previous statistics, which included "only 10 to 15 percent [of cardiac arrest patients] recover without brain damage," according to news reports.
The therapy has been used since the late 1950's "but was subsequently abandoned because of uncertain benefit and difficulties with its use," according to a 2003 report on the therapy from the American Heart Association (AHA).
Scientists at the University of Pennsylvania in Philadelphia have reported that surgery to remove the esophagus among esophageal cancer patients is being underused and may be costing patients dearly.
According to the study conducted by the researchers, only 34 percent of approximately 2,386 patients who were diagnosed with esophageal cancer from 1997 to 2002 received surgery.
By using LegalView's homepage, at 
full story
printer version
